Imprint

Merz Therapeutics GmbH

Eckenheimer Landstrasse 100

60318 Frankfurt am Main

Germany

Phone: +49-(0)69-15 03-0

Fax: +49-(0)69-15 03-200

Email: dp_therapeutics@merz.de

Management

Merz Therapeutics GmbH

Eckenheimer Landstrasse 100

60318 Frankfurt am Main

Germany

Management: Stefan König, Dr. Stefan-Alexander Albrecht, Michael Schwaninger

Commercial Register: District Court at Frankfurt am Main, HRB 123488

VAT Reg No.: DE344390214

Contents

Merz Therapeutics GmbH

Eckenheimer Landstrasse 100

60318 Frankfurt am Main

Germany

Responsible: Kerstin Piling, Region International Markets

Obligatory texts Hepa-Merz®

EU:

Hepa- Merz®  Granules
Active substance: L-ornithine- L-aspartate
Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose,

For risks and side effects please read package insert and ask your doctor or pharmacist.

Version July 2019

Merz Pharmaceuticals GmbH, 60048 Frankfurt

LATAM:

Hepa- Merz®  Granules
Active substance: L-ornithine- L-aspartate
Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose, aspartame.

For risks and side effects please read package insert and ask your doctor or pharmacist.

Version July 2019

Merz Pharmaceuticals GmbH, 60048 Frankfurt